A Multicentric Open-label Randomized Controlled Study for Evaluating the Improvement of Endothelial Function in Stage II Peripheral Arterial Obstructive Disease Patients Treated With Sulodexide + Conventional Treatment {CT] Vs CT Alone
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Sulodexide (Primary) ; ACE inhibitors; Antiplatelets; Atorvastatin; Captopril; HMG-CoA reductase inhibitors; Lysine acetylsalicylate
- Indications Peripheral arterial occlusive disorders
- Focus Therapeutic Use
- Acronyms AWAOMI2
- Sponsors Alfa Wassermann SpA
- 28 Nov 2019 Planned primary completion date changed from 30 Sep 2019 to 30 Dec 2019.
- 03 Jul 2019 Status changed from not yet recruiting to active, no longer recruiting.
- 09 Jan 2019 Planned End Date changed from 30 Mar 2019 to 30 Mar 2020.